Safety, Tolerability and Pharmacokinetics of L-Ornithine Phenylacetate in Patients with Acute Liver Injury/Failure and Hyperammonemia.

about

The Pharmabiotic Approach to Treat Hyperammonemia.Update on the Therapeutic Management of Hepatic Encephalopathy.

P2860

Q47831420-67F6E13C-C88D-47B8-830F-CE81B60D7843 Q55312369-E253232E-67D5-42A7-BC00-27C4DFE61335

P2860

Safety, Tolerability and Pharmacokinetics of L-Ornithine Phenylacetate in Patients with Acute Liver Injury/Failure and Hyperammonemia.

Item

http://www.wikidata.org/entity/Q45071236

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Safety, Tolerability and Pharm ...... ry/Failure and Hyperammonemia.

@en

Safety, Tolerability and Pharm ...... ry/Failure and Hyperammonemia.

@nl

type

Item

label

Safety, Tolerability and Pharm ...... ry/Failure and Hyperammonemia.

@en

Safety, Tolerability and Pharm ...... ry/Failure and Hyperammonemia.

@nl

prefLabel

Safety, Tolerability and Pharm ...... ry/Failure and Hyperammonemia.

@en

Safety, Tolerability and Pharm ...... ry/Failure and Hyperammonemia.

@nl

P1476

Safety, Tolerability and Pharm ...... ry/Failure and Hyperammonemia.

@en

P2093

A James Hanje

http://www.w3.org/2001/XMLSchema#string

Acute Liver Failure Study Group

http://www.w3.org/2001/XMLSchema#string

Averell Sherker

http://www.w3.org/2001/XMLSchema#string

Bilal Hameed

http://www.w3.org/2001/XMLSchema#string

Daniel Ganger

http://www.w3.org/2001/XMLSchema#string

David Koch

http://www.w3.org/2001/XMLSchema#string

Kristen Clasen

http://www.w3.org/2001/XMLSchema#string

Lanna Little

http://www.w3.org/2001/XMLSchema#string

Michelle Gottfried

http://www.w3.org/2001/XMLSchema#string

R Todd Stravitz

http://www.w3.org/2001/XMLSchema#string

P2860

Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study.

Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio.

Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure.

Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis.

Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients

Neurological complications of acute liver failure: pathophysiological basis of current management and emerging therapies.

Glutamine in the pathogenesis of hepatic encephalopathy: the trojan horse hypothesis revisited.

Lessons from look-back in acute liver failure? A single centre experience of 3300 patients.

Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study.

P304

1003-1013

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.29621

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

William M Lee

P577

2017-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29080224

http://www.w3.org/2001/XMLSchema#string

P932

5826861

http://www.w3.org/2001/XMLSchema#string

Safety, Tolerability and Pharmacokinetics of L-Ornithine Phenylacetate in Patients with Acute Liver Injury/Failure and Hyperammonemia.

about

P2860

P2860

Safety, Tolerability and Pharmacokinetics of L-Ornithine Phenylacetate in Patients with Acute Liver Injury/Failure and Hyperammonemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932